Promising combo aims to shrink bladder tumors before surgery
Disease control
Not yet recruiting
This study tests whether combining two drugs (trastuzumab rezetecan and camrelizumab) before surgery can improve outcomes for people with a certain type of muscle-invasive bladder cancer (HER2-positive). About 44 adults will receive the treatment to see if it helps eliminate canc…
Phase: PHASE2 • Sponsor: Sheng Tai • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC